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We would like to thank Prof. Kawada for his interest in our manuscript (1), which describes a 
preliminary investigation of sleep quality in people with functional neurological disorders (FND). 
Below we respond to Prof. <ĂǁĂĚĂ ?ƐĐŽŵŵĞŶƚƐ ? 
1. Prof. Kawada writes,  ? ?the authors did not explain the opposite direction in beta values of 
anxiety and depression by a regression analysis  ? ?While our paper focuses on the 
relationship between sleep and FND-related functional impairment, Prof. Kawada is correct 
in noticing that, in step 4 of the regression analysis (in Table 2 of Graham & Kyle, 2017(1)), 
anxiety becomes negatively associated with FND-related functional impairment when 
depression is entered into the model. We attribute this effect to shared variance between 
anxiety and depression, with depression being a strong predictor of FND-related functional 
impairment. Variance inflation factors (2.03 and 2.39) and tolerance statistics (0.49 and 
0.42) suggested that it would be acceptable concurrently to include both depression and 
anxiety. However, we agree that a principal components analysis of depression and anxiety 
items could be used to derive an alternative factorial solution that could subsequently be 
entered into the regression model.    
2. Prof. Kawada remarks that,  ?Percentages of medications in anti-depressants and 
benzodiazepines were 52.7% and 9.3%, and the difference of prescription rate would partly 
contribute to the result ? ?tĞĂŐƌĞĞƚŚĂƚŵĞĚŝĐĂƚŝŽŶƵƐĞŵĂǇĐŽ-vary with FND-related 
functional impairment. In addition, it may also act as a proxy for severity of sleep 
disturbance and/or distress, which was captured by our questionnaires. Consistent with our 
aims, we focused on self-reported sleep disturbance in this first study but we concur that 
future studies, using appropriate designs, should investigate a range of potential 
intermediate pathways linking sleep to functional impairment and other outcomes in FND.  
3. ƐƚĂƚĞŵĞŶƚŝƐŵĂĚĞƌĞŐĂƌĚŝŶŐƚŚĞĂŐĞƌĂŶŐĞŽĨŽƵƌƐĂŵƉůĞ ? ?The authors handled relatively 
young patients with having FND-related functional impairment ?. In contrast, the age range 
of our online sample (M = 40.42 years, SD = 10.83) was commensurate with those of 
previous large FND cohort studies (M = 39.1; M = 37.2, SD =13.7) (2, 3) and our clinical 
sample (M = 37.85, SD = 15.96). In addition, FND have variable age of onset, are not 
generally progressive, and can spontaneously remit. Therefore,  ‘age ? or  ‘years with FND ? are 
less likely to be indicators of symptom severity or symptom-related functional impairment 
than in progressive neurological conditions.  
4. Finally, Prof. Kawada writes  ?In addition, difference of clinical symptoms and stages in 
several neurological disorders would also be related to the results. As the number of samples 
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was limited, stratified analysis would be difficult to conduct ? ?tĞĂŐƌĞĞƚŚĂƚŝƚǁŽuld be 
interesting to stratify the sample by FND symptom constellations (for example, those with 
non-epileptic seizures and those with functional motor disorders) and symptom severity, but 
as Dr Kawada notes our sample size and composition does not permit this. Clearly sleep 
disruption is associated with most mental and physical health problems. Nonetheless, we 
should not assume that sleep disruption always represents a consequence of some 
 ?ƉƌŝŵĂƌǇ ?ĐŽŶĚŝƚŝŽŶ ?ƐƵĐŚĂƐĚĞƉƌĞƐƐŝŽŶ ?ZĂƚŚĞƌƚŚĞƌĞĂƉƉĞĂƌƐƚŽďĞĂĐŽŵƉůĞǆďŝ -directional 
relationship between sleep and symptom severity in many conditions (4), and sleep often 
interacts with co-morbidities and medications.  
In summary, we welcome Prof. <ĂǁĂĚĂ ?Ɛ useful comments on our paper. We hope our work will 
stimulate others to investigate sleep in FND and to build upon these preliminary findings.  
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